Thermo Fisher Scientific Inc (TMO)
Cash ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 8,077,000 | 6,151,000 | 3,133,000 | 3,482,000 | 8,524,000 | 2,919,000 | 1,888,000 | 2,752,000 | 4,477,000 | 12,027,000 | 7,023,000 | 5,583,000 | 10,325,000 | 7,540,000 | 5,818,000 | 2,981,000 | 2,399,000 | 1,273,000 | 2,288,000 | 1,106,000 |
| Short-term investments | US$ in thousands | — | — | — | — | 2,000 | 22,000 | 5,000 | 150,000 | — | — | 65,000 | 121,000 | 28,000 | 697,000 | — | 110,000 | — | 7,000 | 6,000 | 9,000 |
| Total current liabilities | US$ in thousands | 14,012,000 | 14,158,000 | 14,112,000 | 15,884,000 | 17,010,000 | 11,118,000 | 10,997,000 | 12,070,000 | 13,436,000 | 7,753,000 | 6,925,000 | 6,995,000 | 10,304,000 | 6,228,000 | 6,013,000 | 5,500,000 | 6,197,000 | 5,844,000 | 7,509,000 | 5,898,000 |
| Cash ratio | 0.58 | 0.43 | 0.22 | 0.22 | 0.50 | 0.26 | 0.17 | 0.24 | 0.33 | 1.55 | 1.02 | 0.82 | 1.00 | 1.32 | 0.97 | 0.56 | 0.39 | 0.22 | 0.31 | 0.19 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($8,077,000K
+ $—K)
÷ $14,012,000K
= 0.58
The cash ratio of Thermo Fisher Scientific Inc. has shown some fluctuations over the past eight quarters. The ratio indicates the company's ability to cover its short-term liabilities using its cash and cash equivalents.
In Q4 2023, the cash ratio was 0.81, reflecting an improvement compared to the previous quarter's ratio of 0.66. This suggests that the company had a higher level of cash and cash equivalents relative to its current liabilities in the latest quarter.
Looking at the trend over the past year, the cash ratio has generally been above 0.4, indicating that Thermo Fisher Scientific Inc. has maintained a strong ability to meet its short-term obligations with its available cash resources.
While the cash ratio peaked in Q4 2023 at 0.81, it has shown some variability over the quarters, reaching a low of 0.42 in Q1 2023. This variability may reflect fluctuations in the company's cash position and short-term liabilities during the period.
Overall, the upward trend in the cash ratio suggests that Thermo Fisher Scientific Inc. has been effective in managing its liquidity position and maintaining a healthy level of cash reserves relative to its short-term obligations.
Peer comparison
Dec 31, 2023